Our research is creating more transplant options for people with leukemia and other diseases
Cord blood donors can be identified for essentially all patients in need of hematopoietic cell transplant
We are working toward a better understanding of how cord blood cells engraft (take hold in a patient), improving conditioning regimens, and developing standards of care for infection prevention.
Using a method we developed to multiply (“expand”) cord blood cells, we are creating opportunities for using these cells as a bridge therapy of infection-fighting cells to improve patients’ transplant survival and reduce infection risk during chemotherapy.
The laboratory and clinical research components of our team are working together collaborating with our colleagues across Fred Hutch to improve outcomes for cord blood transplant recipients and develop innovative new therapies.